3 unknown. 3 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Unknown 3 |
| Phase 2 | 2 | Unknown 2 |
Follow Hyperuricemia: new trials by email Literature Review of Hyperuricemia trials Research Report on Hyperuricemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase II/III Study of AR882 Capsules Compared to Febuxostat Tablets in Patients with Primary Gout and Hyperuricemia Febuxostat 20MG Tablets, Febuxostat 20MG Placebo, AR882 25MG - Primary Gout, Hyperuricemia | Phase 2 / Phase 3 | Unknown | Guangzhou Ruianbo Pharmaceutical Technology Co., Ltd | 636 | 2024-04-22 | 2024-09-19 |
| Effects of Allopurinol on Inflammation and Ultrasonographic Changes in People With Elevated Uric Acid But no Symptoms Allopurinol Pill - Musculoskeletal Degeneration, Inflammation | Phase 3 | Unknown | Instituto Nacional de Cardiologia Ignacio Chavez | 200 | 2019-08-30 | 2020-01-23 |
| Long-term Prednisone Use for End-stage Heart Failure prednisone - Heart Failure, Hyperuricemia | Phase 2 / Phase 3 | Unknown | Hebei Medical University | 90 | 2013-12-01 | 2017-01-12 |
Gout (1) · Heart Failure (1) · Inflammation (1)
Pathologic Processes (3) · Pathological Conditions, Signs and Symptoms (3) · Arthritis (1) · Cardiovascular Diseases (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Crystal Arthropathies (1) · Genetic Diseases, Inborn (1) · Heart Diseases (1) · Joint Diseases (1) · Metabolic Diseases (1) · Metabolism, Inborn Errors (1) · Musculoskeletal Diseases (1) · Nutritional and Metabolic Diseases (1) · Purine-Pyrimidine Metabolism, Inborn Errors (1) · Rheumatic Diseases (1)
Allopurinol (1) · Febuxostat (1) · Prednisone (1)
Guangzhou Ruianbo Pharmaceutical Technology Co., Ltd (1) · Hebei Medical University (1) · Instituto Nacional de Cardiologia Ignacio Chavez (1)
China (2) · Mexico (1)